Quince Therapeutics, Inc. (QNCX): SC 13G/A filed Apr 27, 2021

Form type

SC 13G/A

Filing date

Apr 27, 2021

Accession number

0001193125-21-133435

Filer

Quince Therapeutics, Inc. (CIK 1662774)